Susceptibility of Superbug Clostridioides difficile to Vancomycin is Decreasing
                
                
                    According to research, vancomycin, a first-line antibiotic used in the treatment of Clostridioides difficile infection, may be decreasing in effectiveness as rates of antimicrobial resistance continue to grow.